Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SPHINX is an inhibitor of serine/arginine-rich protein kinase 1 (SRPK1; IC50 = 0.88 µM).1 It is selective for SRPK1 over SRPK2 (IC50 = >10 µM). SPHINX (10 µM) inhibits EGF-induced increases in phosphorylation of serine/arginine-rich splicing factor 1 (SRSF1) in ARPE-19 retinal epithelial cells. It decreases lesion area and choroidal neovascularization in mouse eyes in a model of laser-induced photocoagulation when administered at a dose of 25 ng/eye. SPHINX reduces tumor growth in a PC3 prostate cancer mouse xenograft model.2
WARNING This product is not for human or veterinary use.
1. Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD. Invest. Ophthalmol. Vis. Sci. 54(9), 6052-6062 (2013).
2. Serine-